Literature DB >> 10788500

Overexpression of C-terminal Src kinase blocks 14, 15-epoxyeicosatrienoic acid-induced tyrosine phosphorylation and mitogenesis.

J K Chen1, J Capdevila, R C Harris.   

Abstract

We have previously reported that 14,15-epoxyeicosatrienoic acid (14, 15-EET) is a potent mitogen for the renal epithelial cell line, LLCPKcl4. This mitogenic effect is dependent upon activation of a protein-tyrosine kinase cascade that results in activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Because of suggestive evidence that 14,15-EET also activated Src in these cells, we stably transfected LLCPKcl4 with an expression construct of the C-terminal Src kinase (CSK), which inhibits Src family kinase activity. In vitro Src kinase activity assays confirmed that in empty vector-transfected cells (Vector cells), 14, 15-EET increased Src kinase activity, while in clones overexpressing CSK mRNA and immunoreactive protein (CSK cells), 14,15-EET-induced activation of Src was almost completely blocked (94% inhibition). Of interest, epidermal growth factor (EGF) and fetal bovine serum (FBS) also increased Src activity in Vector cells, but not in CSK cells, further confirming the ability of CSK overexpression to prevent Src activation. CSK cells failed to increase [(3)H]thymidine incorporation in response to exogenous 14,15-EET. In contrast, both EGF and FBS significantly increased [(3)H]thymidine incorporation in CSK cells. Immunoprecipitation with anti-phosphotyrosine antibodies and immunoblotting with an antibody against extracellular signal-regulated kinase (ERK) indicated that in CSK cells, 14,15-EET failed to activate ERK1 and ERK2; however, EGF- and FBS-induced activation of ERKs was not different from that seen in Vector cells. In Vector cells, the 14,15-EET-stimulated tyrosine phosphorylation of ERKs was blocked by pretreatment with 1 microm PP2, a selective inhibitor of Src kinases. The present study demonstrates that 14, 15-EET exerts its mitogenic effects predominantly through a Src kinase-mediated pathway, which is the most upstream signaling step determined to date in the 14,15-EET-activated tyrosine kinase cascade in renal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788500     DOI: 10.1074/jbc.275.18.13789

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Mechanism of v-Src- and mitogen-activated protein kinase-induced reduction of gap junction communication.

Authors:  G Trevor Cottrell; Rui Lin; Bonnie J Warn-Cramer; Alan F Lau; Janis M Burt
Journal:  Am J Physiol Cell Physiol       Date:  2002-10-16       Impact factor: 4.249

2.  An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells.

Authors:  Mohammad B Uddin; Kartik R Roy; Salman B Hosain; Sachin K Khiste; Ronald A Hill; Seetharama D Jois; Yunfeng Zhao; Alan J Tackett; Yong-Yu Liu
Journal:  Biochem Pharmacol       Date:  2018-12-19       Impact factor: 5.858

3.  Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis.

Authors:  Stephanie Norwood; Jie Liao; Bruce D Hammock; Guang-Yu Yang
Journal:  Am J Transl Res       Date:  2010-07-22       Impact factor: 4.060

4.  Angiotensin II stimulates fibronectin protein synthesis via a Gβγ/arachidonic acid-dependent pathway.

Authors:  Larry D Alexander; Yaxian Ding; Suganthi Alagarsamy; Xiaolan Cui
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-11

5.  Lysosomal acid lipase promotes cholesterol ester metabolism and drives clear cell renal cell carcinoma progression.

Authors:  Jun Wang; Mingyue Tan; Jifu Ge; Ping Zhang; Jie Zhong; Le Tao; Qiong Wang; Xuemei Tong; Jianxin Qiu
Journal:  Cell Prolif       Date:  2018-03-23       Impact factor: 6.831

6.  Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis.

Authors:  J K Chen; J Capdevila; R C Harris
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.

Authors:  Yong-Yu Liu; Vineet Gupta; Gauri A Patwardhan; Kaustubh Bhinge; Yunfeng Zhao; Jianxiong Bao; Harihara Mehendale; Myles C Cabot; Yu-Teh Li; S Michal Jazwinski
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

8.  Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite.

Authors:  Jianchun Chen; Jian-Kang Chen; John R Falck; Jagadeesh Setti Guthi; Siddam Anjaiah; Jorge H Capdevila; Raymond C Harris
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis.

Authors:  Sergey Y Cheranov; Manjula Karpurapu; Dong Wang; Baolin Zhang; Richard C Venema; Gadiparthi N Rao
Journal:  Blood       Date:  2008-04-11       Impact factor: 22.113

10.  Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways.

Authors:  ZhiJian Wang; Yuan Wei; John R Falck; Krishnam Raju Atcha; Wen-Hui Wang
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.